Movement at HedgePath, page-5

"Basal Cell Carcinoma Nevus Syndrome is a rare condition caused by a genetic mutation which affects the skin and eyes, nervous, endocrine and skeletal systems.
BCCNS occurs 1 in 40000 in the US" - https://bccns.org/bccns/

So thats, like, 8000 cases in the US, divide that based on a life expectancy, maybe only 100 new cases per year.

Story here says they can pay $13,000 a month in the US for treatment for rare cancer types (so glad we have medicare)
http://www.reuters.com/article/us-usa-healthcare-cancer-costs-idUSKBN1750FU

I dont know how many months treatment they might typically need for something like that, i guess it could be 5 million a year for mayne.

Looking at it another way, HPPI has a market cap of 150M, and there is a fair bit of risk in developing these, so to get a good return i guess they would be hoping for something like 30M a year earnings. Which would be 15M for MYX, which is only 1c per share... which really isnt very exciting at all now that i have gone through all that